Long-Term Follow-up Study for Multiple Myeloma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3102 Study (NCT00103662).
CompletedOBSERVATIONAL
Enrollment
164
Participants
Timeline
Start Date
June 30, 2006
Primary Completion Date
July 31, 2011
Study Completion Date
July 31, 2011
Conditions
Multiple MyelomaAutologous Transplantation
Interventions
DRUG
Placebo
DRUG
plerixafor
DRUG
granulocyte colony-stimulating factor (G-CSF)
All Listed Sponsors
lead
Genzyme, a Sanofi Company
INDUSTRY
NCT00741780 - Long-Term Follow-up Study for Multiple Myeloma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3102 Study (NCT00103662). | Biotech Hunter | Biotech Hunter